Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 19.5B | 19.2B | 21.3B | 19.1B |
Cost of revenue | 18.2B | 18.0B | 19.0B | 17.7B |
Gross profit | 1.3B | 1.1B | 2.2B | 1.4B |
Operating expense | ||||
Research & development | 126M | 143M | 109M | 106M |
Selling general and admin | 1.2B | 1.3B | 1.2B | 1.0B |
Other operating expenses | — | 2.0B | 10M | 73M |
Operating income | 1M | -2.4B | 1.0B | 232M |
Non operating interest income | ||||
Income | 214M | 302M | 366M | 330M |
Expense | 1.2B | 2.1B | 1.1B | 1.2B |
Other income expense | 2.2B | -4.2B | -1.2B | -4.9B |
Pretax income | 816M | -8.3B | -1.3B | -6.0B |
Tax provision | 184M | -2.4B | -444M | -2.1B |
Net income | 632M | -5.9B | -868M | -3.9B |
Basic EPS | 1.8 | — | -1.5 | -9.4 |
Diluted EPS | 1.8 | — | -1.5 | -9.4 |
Basic average shares | 398.5M | — | 398.5M | 398.5M |
Diluted average shares | 398.5M | — | 398.5M | 398.5M |
EBITDA | 1.2B | -1.3B | 2.7B | 1.3B |
Net income from continuing op. | 816M | -8.3B | -1.3B | -6.0B |
Minority interests | 66M | 240M | 277M | 171M |
Preferred stock dividends | — | — | — | — |